GO:0008206 bile acid metabolic process: Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0008206 bile acid metabolic process describes the chemical reactions and pathways involving bile acids, a group of steroid carboxylic acids occurring in bile, where they are present as the sodium salts of their amides with glycine or taurine.
• Bile acid metabolism is a complex, multi-organ process that converts cholesterol into primary bile acids in the liver, followed by microbial biotransformation in the intestine to secondary bile acids [1, 2].
• Key enzymes include CYP7A1, CYP8B1, CYP27A1, and CYP7B1 for synthesis; BACS and BAAT for conjugation; and ASBT, NTCP, and BSEP for transport [2, 3].
• Bile acids are signaling molecules that activate nuclear receptors such as FXR and TGR5, regulating their own synthesis, glucose and lipid metabolism, and inflammation [5, 7].
• Dysregulation of bile acid metabolism is linked to cholestatic liver diseases, metabolic disorders, and cancers of the liver and gastrointestinal tract [3, 7].
• CRISPR-based models (knockout, point mutation, knock-in, overexpression) enable precise dissection of bile acid pathway genes and their roles in disease [1, 3].
Description
Bile acid metabolic process (GO:0008206) encompasses the chemical reactions and pathways involving bile acids, a group of steroid carboxylic acids occurring in bile, where they are present as the sodium salts of their amides with glycine or taurine. This process is essential for the digestion and absorption of dietary fats and fat-soluble vitamins, and it also serves as a major route for cholesterol elimination [2, 8]. Beyond their classical roles in lipid digestion, bile acids act as potent signaling molecules that regulate glucose, lipid, and energy metabolism through receptors such as the farnesoid X receptor (FXR) and the G protein-coupled bile acid receptor TGR5 [3, 5]. The study of bile acid metabolism is therefore central to understanding liver physiology, metabolic homeostasis, and the pathogenesis of cholestatic and metabolic diseases [1, 3]. Researchers investigate this process using a combination of biochemical assays, genetic models, and advanced omics technologies to uncover the enzymes, transporters, and regulatory networks involved [2, 4].
bile acid metabolic process At A Glance
| GO ID | GO:0008206 |
|---|---|
| GO term | bile acid metabolic process |
| Ontology | biological_process |
| Synonym | bile acid metabolism |
| Definition | The chemical reactions and pathways involving bile acids, a group of steroid carboxylic acids occurring in bile, where they are present as the sodium salts of their amides with glycine or taurine. |
| Major function | Synthesis, conjugation, transport, and microbial modification of bile acids for lipid digestion and signaling. |
| Key enzymes | CYP7A1, CYP8B1, CYP27A1, CYP7B1, BACS, BAAT |
| Key transporters | NTCP, BSEP, ASBT, OSTα/β |
| Regulatory receptors | FXR (NR1H4), TGR5 (GPBAR1), PXR, VDR |
What Is GO:0008206?
The bile acid metabolic process (GO:0008206) is defined as the chemical reactions and pathways involving bile acids, a group of steroid carboxylic acids occurring in bile, where they are present as the sodium salts of their amides with glycine or taurine. In essence, it covers the synthesis of bile acids from cholesterol, their conjugation to glycine or taurine, their transport and secretion into bile, their microbial transformation in the gut, and their reabsorption and recycling via enterohepatic circulation [2, 4, 6].
Why Is bile acid metabolic process Important in Cell Biology?
Bile acid metabolism is critically important because it governs the absorption of dietary fats and fat-soluble vitamins, maintains cholesterol homeostasis, and produces signaling molecules that regulate systemic metabolic and inflammatory pathways [2, 3]. Disruptions in this process contribute to a wide range of diseases, including cholestatic liver injury, non-alcoholic fatty liver disease, type 2 diabetes, and gastrointestinal cancers [1, 7]. Understanding the molecular players and regulatory mechanisms of bile acid metabolism is therefore essential for developing targeted therapies and for interpreting the impact of genetic and environmental factors on human health [3, 5].
• Facilitates digestion and absorption of dietary lipids and fat-soluble vitamins.
• Represents a major pathway for cholesterol catabolism and elimination.
• Generates signaling molecules that activate FXR and TGR5, influencing glucose and lipid metabolism [3, 5].
• Regulates its own synthesis via negative feedback through FXR in the liver and intestine.
• Modulates gut microbiota composition and is in turn modified by microbial enzymes [4, 6].
• Dysregulation is associated with cholestatic liver diseases such as primary biliary cholangitis and primary sclerosing cholangitis.
• Implicated in metabolic disorders including obesity, insulin resistance, and non-alcoholic steatohepatitis [1, 3].
• Altered bile acid metabolism is observed in hepatocellular carcinoma and colorectal cancer [1, 3].
• Serves as a target for drug development, including FXR agonists and bile acid sequestrants [3, 5].
• Provides biomarkers for liver function and metabolic health.
What Happens During bile acid metabolic process?
Bile Acid Synthesis from Cholesterol
In simple terms: The liver converts cholesterol into bile acids through a series of enzymatic reactions.
Bile acid synthesis occurs via two main pathways: the classical (neutral) pathway initiated by CYP7A1, and the alternative (acidic) pathway initiated by CYP27A1. In the classical pathway, CYP7A1 catalyzes the rate-limiting step, converting cholesterol to 7α-hydroxycholesterol, which is then further modified by CYP8B1 and other enzymes to produce cholic acid (CA) and chenodeoxycholic acid (CDCA) [2, 8]. The alternative pathway produces mainly CDCA and involves CYP27A1 and CYP7B1. These primary bile acids are then conjugated to glycine or taurine by bile acid-CoA:amino acid N-acyltransferase (BAAT) after activation by bile acid-CoA synthetase (BACS).
Conjugation and Transport
In simple terms: Bile acids are tagged with glycine or taurine to make them more water-soluble, then pumped out of the liver into bile.
Conjugation of bile acids with glycine or taurine increases their solubility and reduces their toxicity. This process is catalyzed by BAAT in the liver. Conjugated bile acids are then secreted into the bile canaliculi by the bile salt export pump (BSEP, ABCB11) [2, 3]. On the basolateral side, the sodium-taurocholate cotransporting polypeptide (NTCP, SLC10A1) mediates uptake of bile acids from the portal blood into hepatocytes, while the organic solute transporter OSTα/β facilitates efflux.
Microbial Biotransformation in the Gut
In simple terms: Gut bacteria chemically modify bile acids, creating secondary bile acids.
Upon reaching the intestine, primary bile acids undergo biotransformation by the gut microbiota [4, 6]. Bacterial enzymes such as bile salt hydrolase (BSH) deconjugate bile acids, and 7α-dehydroxylase converts primary bile acids to secondary bile acids, including deoxycholic acid (DCA) and lithocholic acid (LCA) [4, 6]. These secondary bile acids can be reabsorbed or excreted, and they exhibit different signaling properties and toxicity profiles.
Enterohepatic Circulation
In simple terms: Bile acids are recycled between the liver and intestine to conserve them.
The enterohepatic circulation is a highly efficient process that reabsorbs about 95% of bile acids from the ileum and colon back to the liver. The apical sodium-dependent bile acid transporter (ASBT, SLC10A2) in the ileum mediates uptake, and OSTα/β facilitates basolateral efflux into the portal circulation. In the liver, NTCP takes up bile acids, completing the cycle. This circulation is tightly regulated by FXR, which modulates the expression of transporters and enzymes to maintain bile acid homeostasis.
Regulation by Nuclear Receptors
In simple terms: Bile acids control their own production by activating receptors that turn genes on or off.
Bile acids are ligands for the nuclear receptor FXR (NR1H4) and the membrane receptor TGR5 (GPBAR1) [3, 5]. Activation of FXR in the liver induces the expression of the small heterodimer partner (SHP, NR0B2), which represses CYP7A1 transcription, thereby inhibiting bile acid synthesis. In the intestine, FXR activation induces fibroblast growth factor 19 (FGF19 in humans, FGF15 in mice), which signals through FGFR4 on hepatocytes to further suppress CYP7A1. TGR5 activation by bile acids stimulates GLP-1 secretion and energy expenditure, linking bile acids to metabolic regulation.
Key Genes Involved in GO:0008206 bile acid metabolic process
The following genes encode key enzymes, transporters, and receptors involved in bile acid metabolic process.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CYP7A1 | Rate-limiting enzyme in classical bile acid synthesis | Target for studying cholesterol catabolism and feedback regulation |
| CYP8B1 | Sterol 12α-hydroxylase, determines CA/CDCA ratio | Modulates bile acid composition and hydrophobicity |
| CYP27A1 | Sterol 27-hydroxylase, initiates alternative pathway | Linked to cerebrotendinous xanthomatosis |
| CYP7B1 | Oxysterol 7α-hydroxylase in alternative pathway | Defects cause liver disease and neuropathy |
| BACS (SLC27A5) | Bile acid-CoA synthetase, activates bile acids for conjugation | Essential for conjugation and detoxification |
| BAAT | Bile acid-CoA:amino acid N-acyltransferase, conjugates bile acids | Mutations cause hypercholanemia |
| NTCP (SLC10A1) | Sodium-taurocholate cotransporting polypeptide, hepatic uptake | Mediates HBV entry and bile acid uptake [2, 3] |
| BSEP (ABCB11) | Bile salt export pump, canalicular secretion | Mutations cause progressive familial intrahepatic cholestasis |
| ASBT (SLC10A2) | Apical sodium-dependent bile acid transporter, ileal uptake | Target for bile acid malabsorption therapies |
| OSTα (SLC51A) | Organic solute transporter alpha, basolateral efflux | Facilitates bile acid transport in intestine and liver |
| OSTβ (SLC51B) | Organic solute transporter beta, partner of OSTα | Essential for OST function |
| FXR (NR1H4) | Nuclear receptor activated by bile acids, regulates synthesis and transport | Central regulator of bile acid homeostasis |
| TGR5 (GPBAR1) | G protein-coupled bile acid receptor, mediates metabolic effects | Involved in energy expenditure and glucose metabolism |
| SHP (NR0B2) | Small heterodimer partner, represses CYP7A1 | Mediates FXR-dependent feedback inhibition |
| FGF19 | Fibroblast growth factor 19, intestinal hormone suppressing CYP7A1 | Regulates bile acid synthesis in humans |
| FGFR4 | Fibroblast growth factor receptor 4, mediates FGF19 signaling | Required for feedback repression of CYP7A1 |
| BSH | Bile salt hydrolase, microbial deconjugation | Modulates bile acid pool and host metabolism |
| 7α-dehydroxylase | Microbial enzyme converting primary to secondary bile acids | Produces DCA and LCA, affects colon health |
How Is bile acid metabolic process Regulated?
Bile acid metabolism is tightly regulated at multiple levels. The nuclear receptor FXR plays a central role by sensing bile acid levels and inducing negative feedback mechanisms. In the liver, FXR activation induces SHP, which inhibits CYP7A1 transcription. In the intestine, FXR induces FGF19, which circulates to the liver and activates FGFR4 to suppress CYP7A1. Additionally, the membrane receptor TGR5 mediates rapid signaling effects of bile acids on energy metabolism and inflammation. Microbial modifications also influence bile acid pool composition and signaling, creating a bidirectional relationship between the host and gut microbiota [4, 6].
bile acid metabolic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| BSEP (ABCB11) | Progressive familial intrahepatic cholestasis | Knockout mouse or patient-derived organoids |
| FXR (NR1H4) | Cholestasis, metabolic syndrome | Liver-specific knockout or knock-in of constitutively active FXR |
| CYP7A1 | Hypercholesterolemia, gallstone disease | Overexpression or knockout in hepatocytes |
| TGR5 (GPBAR1) | Obesity, insulin resistance | Knockout mouse and TGR5 agonist treatment |
| BAAT | Hypercholanemia | Point mutation knock-in to mimic human mutations |
Cholestatic Liver Diseases
Cholestasis is characterized by impaired bile flow, leading to accumulation of toxic bile acids in the liver and subsequent inflammation and oxidative stress. Mutations in BSEP (ABCB11) cause progressive familial intrahepatic cholestasis type 2, while defects in FXR signaling contribute to cholestatic injury [2, 7]. Therapeutic strategies targeting FXR, such as obeticholic acid, are used to treat primary biliary cholangitis.
Metabolic Disorders
Dysregulated bile acid metabolism is associated with obesity, insulin resistance, and non-alcoholic fatty liver disease [1, 3]. Bile acids influence glucose and lipid homeostasis through FXR and TGR5, and alterations in gut microbiota can impact bile acid profiles and metabolic outcomes [1, 4]. FXR agonists are being investigated for their potential to improve metabolic parameters.
Gastrointestinal Cancers
Secondary bile acids such as deoxycholic acid (DCA) and lithocholic acid (LCA) have been implicated in promoting colorectal cancer through DNA damage and activation of inflammatory pathways. In hepatocellular carcinoma, altered bile acid signaling can promote tumorigenesis via FXR and TGR5 [1, 3]. Understanding the role of bile acids in cancer may lead to novel preventive and therapeutic approaches.
From bile acid metabolic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of CYP7A1 affect bile acid pool and cholesterol levels? | CYP7A1 knockout mouse or HepG2 knockout cells |
| What is the effect of a specific FXR point mutation on ligand binding? | Point mutation knock-in in cell lines or mice |
| Can overexpression of FGF19 suppress bile acid synthesis? | FGF19 overexpression in hepatocytes or transgenic mice |
| How does BSEP deficiency alter bile acid transport? | BSEP knockout or knock-in of patient mutations in cell models |
| What is the role of TGR5 in glucose homeostasis? | TGR5 knockout and overexpression models |
| How do gut microbiota modify bile acids? | Gnotobiotic mice with defined bacterial strains [4, 6] |
How to Study the bile acid metabolic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| LC-MS/MS | Bile acid species and concentrations | Quantifying bile acid pool in tissues and biofluids |
| RNA-seq | Transcriptome-wide gene expression | Identifying differentially expressed bile acid pathway genes |
| Western blot | Protein expression and modifications | Validating changes in enzyme levels |
| 16S rRNA sequencing | Microbial community composition | Linking microbiota to bile acid metabolism |
| Metabolomics | Global metabolite profiles | Discovering novel bile acid derivatives |
| CRISPR screening | Gene function at scale | Identifying regulators of bile acid synthesis |
| ChIP-seq | Genome-wide binding of transcription factors | Mapping FXR binding sites |
| Reporter assays | Transcriptional activity | Measuring FXR or TGR5 activation |
Biochemical Assays for Bile Acids
Quantification of bile acids in serum, bile, urine, and feces is typically performed using liquid chromatography-tandem mass spectrometry (LC-MS/MS) or enzymatic assays. These methods allow researchers to measure individual bile acid species and calculate pool sizes and composition, providing insights into pathway activity.
Gene Expression Analysis
RNA-seq and quantitative PCR are used to measure the expression of genes involved in bile acid synthesis, transport, and regulation, such as CYP7A1, BSEP, and FXR [2, 5]. These techniques help identify transcriptional changes in response to genetic or pharmacological interventions.
Protein and Post-Translational Modifications
Western blotting, immunoprecipitation, and mass spectrometry-based proteomics can assess protein levels and modifications of bile acid enzymes and transporters. For example, phosphorylation of FXR or acetylation of CYP7A1 can affect their activity.
Microbiome and Metabolomics
16S rRNA sequencing and metagenomics reveal the composition of gut microbiota, while metabolomics profiles bile acid metabolites [4, 6]. These approaches uncover the bidirectional interactions between host bile acids and microbial communities.
How CRISPR Can Be Used to Study GO:0008206 bile acid metabolic process
Knockout
CRISPR knockout (KO) models are used to completely abolish the function of genes involved in bile acid metabolism, such as CYP7A1, BSEP, or FXR, to study their roles in bile acid synthesis, transport, and signaling [1, 2]. These models can be generated in cell lines (e.g., HepG2, Huh7) or animal models to assess effects on bile acid pool, liver injury, and metabolic parameters.
Point Mutation
Point mutation knock-in models allow the introduction of specific disease-associated mutations, such as those in BSEP or FXR, to study their impact on protein function and bile acid homeostasis [2, 5]. These models are valuable for understanding genotype-phenotype relationships and for testing targeted therapies.
Knock-in
Knock-in models can be used to tag endogenous proteins with reporters (e.g., GFP) or to overexpress a gene of interest under a specific promoter. For bile acid research, knock-in of human FGF19 or constitutively active FXR can help dissect signaling pathways.
Overexpression
CRISPR activation (CRISPRa) or traditional overexpression constructs enable sustained high-level expression of genes such as CYP7A1 or TGR5 to study their effects on bile acid metabolism and metabolic phenotypes. Overexpression models are useful for gain-of-function studies and drug screening.
How EDITGENE Supports bile acid metabolic process Research
Researchers studying bile acid metabolic process-related genes often need to determine whether a candidate gene is causally involved in bile acid synthesis, transport, or signaling, and how specific mutations affect protein function. EDITGENE provides a comprehensive suite of CRISPR-based services to generate precisely engineered cell and animal models, enabling rigorous functional studies and target validation.
Contact EDITGENE today to design your custom CRISPR model for bile acid metabolic process research.
Frequently Asked Questions About bile acid metabolic process
What is bile acid metabolic process?
Bile acid metabolic process (GO:0008206) encompasses the chemical reactions and pathways involving bile acids, a group of steroid carboxylic acids occurring in bile, where they are present as the sodium salts of their amides with glycine or taurine.
What genes are involved in bile acid metabolism?
Key genes include CYP7A1, CYP8B1, CYP27A1, CYP7B1, BACS, BAAT, NTCP, BSEP, ASBT, OSTα/β, FXR, TGR5, SHP, FGF19, and FGFR4 [2, 5].
How is bile acid synthesis regulated?
Bile acid synthesis is regulated by a negative feedback loop involving FXR, SHP, and FGF19, which suppress CYP7A1 expression.
What are primary and secondary bile acids?
Primary bile acids (cholic acid and chenodeoxycholic acid) are synthesized in the liver, while secondary bile acids (deoxycholic acid and lithocholic acid) are produced by microbial modification in the intestine [4, 6].
What diseases are associated with bile acid metabolism?
Dysregulation is linked to cholestatic liver diseases, metabolic disorders, and gastrointestinal cancers [1, 3, 7].
How can CRISPR be used to study bile acid metabolism?
CRISPR knockout, point mutation, knock-in, and overexpression models allow precise manipulation of genes to study their roles in bile acid synthesis, transport, and signaling [1, 2].
What is the role of FXR in bile acid metabolism?
FXR is a nuclear receptor activated by bile acids that induces SHP and FGF19 to inhibit CYP7A1, thereby reducing bile acid synthesis.
What is enterohepatic circulation?
Enterohepatic circulation is the recycling of bile acids from the intestine back to the liver, mediated by transporters such as ASBT and NTCP.
How does gut microbiota affect bile acid metabolism?
Gut bacteria deconjugate and dehydroxylate bile acids, converting primary to secondary bile acids and influencing host signaling [4, 6].
What methods are used to study bile acid metabolism?
Common methods include LC-MS/MS for bile acid quantification, RNA-seq for gene expression, and CRISPR screening for functional genomics [2, 1].
Conclusion
Bile acid metabolic process (GO:0008206) is a fundamental biological pathway with far-reaching implications for digestion, metabolism, and disease. The coordinated actions of hepatic enzymes, transporters, nuclear receptors, and gut microbiota maintain bile acid homeostasis, and their dysregulation contributes to cholestatic liver injury, metabolic disorders, and cancer [1, 2, 3, 5, 7]. Advances in CRISPR-based models and multi-omics technologies are accelerating the discovery of novel therapeutic targets and biomarkers within this pathway [1, 5]. Continued research into bile acid metabolism promises to yield new insights into human health and disease.
References
- 1. Cai J et al.. 2022. Bile acid metabolism and signaling, the microbiota, and metabolic disease.. Pharmacol Ther 237:108238 PMID: 35792223
- 2. Chiang JY. 2013. Bile acid metabolism and signaling.. Compr Physiol 3(3):1191-212 PMID: 23897684
- 3. Li T et al.. 2014. Bile acid signaling in metabolic disease and drug therapy.. Pharmacol Rev 66(4):948-83 PMID: 25073467
- 4. Ramírez-Pérez O et al.. 2017. The Role of the Gut Microbiota in Bile Acid Metabolism.. Ann Hepatol 16(Suppl. 1: s3-105.):s15-s20 PMID: 29080339
- 5. Chiang JYL et al.. 2022. Discovery of farnesoid X receptor and its role in bile acid metabolism.. Mol Cell Endocrinol 548:111618 PMID: 35283218
- 6. Ridlon JM et al.. 2016. Consequences of bile salt biotransformations by intestinal bacteria.. Gut Microbes 7(1):22-39 PMID: 26939849
- 7. Wang MQ et al.. 2024. Wedelolactone alleviates cholestatic liver injury by regulating FXR-bile acid-NF-κB/NRF2 axis to reduce bile acid accumulation and its subsequent inflammation and oxidative stress.. Phytomedicine 122:155124 PMID: 38014837
- 8. Danielsson H et al.. 1975. Bile acid metabolism.. Annu Rev Biochem 44:233-53 PMID: 1094911
